Intravenous Paracetamol Dosing
For adults, administer 1000 mg IV every 6 hours (maximum 4 g/24 hours); for patients with hepatic impairment or low body weight (<50 kg), reduce to 2-3 g/24 hours; for children, use 15 mg/kg IV every 6 hours (maximum 60 mg/kg/24 hours, not exceeding 4 g/24 hours). 1, 2
Adult Dosing
Standard adult dose: 1000 mg IV every 4-6 hours, with a maximum of 4000 mg in 24 hours 2, 3, 4. This dosing has been validated in multiple clinical trials for postoperative pain and fever management, showing significant analgesic efficacy compared to placebo 3.
Administration details:
- Infuse over 15 minutes for optimal safety
- Can be given without regard to meals
- Effective for both acute pain and fever control, with significant temperature reduction within 30 minutes 4
Pediatric Dosing
Weight-based dosing is essential:
- 15 mg/kg per dose every 6 hours
- Maximum single dose: 15 mg/kg
- Maximum daily dose: 60 mg/kg/24 hours (not to exceed 4 g/24 hours) 1, 3
The pediatric formulation has demonstrated equivalent efficacy to propacetamol 30 mg/kg in surgical patients and infection-induced fever 3.
Special Populations: Hepatic Impairment
This is a critical consideration given paracetamol's hepatotoxicity risk. For patients with chronic liver disease or cirrhosis, reduce the maximum daily dose to 2-3 g/24 hours 5, 6. This recommendation is based on evidence showing paracetamol can be safely used at these lower doses even in cirrhotic patients, though higher doses carry significant risk of hepatotoxicity 6.
Additional risk factors requiring dose reduction:
- Age >80 years
- Body weight <50 kg
- Malnutrition
- Prolonged use (>2 days at higher doses) 7
For these susceptible patients, consider a maximum of 3 g/24 hours with liver function monitoring 7, 5.
Critical Safety Considerations
Hepatotoxicity can occur even at therapeutic doses in susceptible populations, though the incidence is low (approximately 1.2 cases per year in population studies) 7. The identified risk factors—advanced age, low body weight, malnutrition, and prolonged exposure—should trigger dose reduction and monitoring 7.
In children, cumulative doses exceeding 75 mg/kg/day for more than 2 days warrant evaluation for liver injury with transaminases, coagulation studies, and paracetamol levels 8. If liver injury is detected, initiate N-acetylcysteine regardless of paracetamol concentration 8.
Contraindications:
- Known paracetamol allergy
- Concurrent use of other paracetamol-containing products 2
Clinical Context
IV paracetamol demonstrates superior pharmacokinetics compared to oral formulations, with faster onset and more predictable absorption 3. It is particularly valuable in postoperative settings and when oral administration is not feasible. The drug shows additive or synergistic effects when combined with NSAIDs or opioids, allowing for opioid-sparing multimodal analgesia 9, 10.
For critically ill patients requiring pain management, IV paracetamol serves as a foundational non-opioid analgesic that can be safely combined with other agents 9. However, in patients with severe hepatic impairment or acute liver failure, extreme caution is warranted, and alternative analgesics should be strongly considered 6, 11.